Evidence map›Paper›PMID 28701951›Full record

ArticleFrontiers in pharmacology2017

Pharmacokinetic/Pharmacodynamic Modeling of Tulathromycin against

Qiaoyi Zhou, Guijun Zhang, Qin Wang, Wenguang Liu, Yan Huang, Pengling Yu, Yanqin Li, Huanzhong Ding, Binghu Fang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Susceptibility ofAntibiotics (Basel, Switzerland) · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Kill Rate and Evaluation ofFrontiers in veterinary science · 2021
    Article
  15. Frontiers in veterinary science · 2021
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Qiaoyi ZhouNational Reference Laboratory of Veterinary Drug Residues, College of Veterinary Medicine, South China Agricultural UniversityGuangzhou, China.
Guijun ZhangGuangdong Wens Dahuanong Biotechnology Co., Ltd.Yunfu, China.
Qin WangNational Reference Laboratory of Veterinary Drug Residues, College of Veterinary Medicine, South China Agricultural UniversityGuangzhou, China.
Wenguang LiuNational Reference Laboratory of Veterinary Drug Residues, College of Veterinary Medicine, South China Agricultural UniversityGuangzhou, China.
Yan HuangNational Reference Laboratory of Veterinary Drug Residues, College of Veterinary Medicine, South China Agricultural UniversityGuangzhou, China.
Pengling YuNational Reference Laboratory of Veterinary Drug Residues, College of Veterinary Medicine, South China Agricultural UniversityGuangzhou, China.
Yanqin LiNational Reference Laboratory of Veterinary Drug Residues, College of Veterinary Medicine, South China Agricultural UniversityGuangzhou, China.
Huanzhong DingNational Reference Laboratory of Veterinary Drug Residues, College of Veterinary Medicine, South China Agricultural UniversityGuangzhou, China.
Binghu FangNational Reference Laboratory of Veterinary Drug Residues, College of Veterinary Medicine, South China Agricultural UniversityGuangzhou, China.
South China Agricultural University · CNWen's Food Group (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tulathromycin, a macrolide antibiotic, is used for the treatment of respiratory disease in cattle and swine. The aim of our study was to investigate the

Indexed as

ex vivo PK/PDPasteurella multocidaPK/PD parameterstissue cage modeltulathromycin

Identifiers

PMID28701951
PMCPMC5487385
OpenAlexW2727815080

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.